RxDoctor Payments DataLook up a doctor →

Arlyn Valencia, MD

Neurology · Las Vegas, NVNPI 1841205523

Payments from drug & device makers

$18,214in general payments, 2019–2025

Across 925 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Biogen$2K
  • Novartis$2K
  • Livanova USA, Inc.$1K
  • Merz Pharmaceuticals, LLC$1K
  • Sunovion Pharmaceuticals Inc.$813
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)127$1,953
Biogen71$1,563
Novartis109$1,549
Livanova USA, Inc.9$1,329
Merz Pharmaceuticals, LLC37$1,042
Sunovion Pharmaceuticals Inc.64$813
UCB, Inc.29$799
ANI Pharmaceuticals, Inc.15$594
EMD Serono, Inc.28$543
Corium, LLC37$492
Acadia Pharmaceuticals Inc35$490
Harmony Biosciences LLC19$484
AstraZeneca(2 entities)22$427
Lundbeck LLC17$376
Amgen21$350
Teva Pharmaceuticals USA, Inc.16$343
Pfizer23$315
Merz North America, Inc.12$304
Argenx US, Inc.15$280
Neurelis, Inc.13$273
Takeda Pharmaceuticals U.S.A., Inc.11$253
Upsher-smith Laboratories LLC15$241
SK Life Science, Inc.10$231
Biohaven Pharmaceutical Holding Company Ltd.21$216
Biotronik NRO, Inc.2$197
Mallinckrodt Hospital Products Inc.8$178
Impel Pharmaceuticals Inc.18$160
Sanofi8$159
Lilly USA, LLC7$157
Genentech USA, Inc.7$145
Sumitomo Pharma America, Inc.5$119
MDD US Operations, LLC5$96
Banner Life Sciences, LLC5$91
Mallinckrodt Enterprises LLC5$90
Johnson & Johnson(2 entities)5$87
Viiv Healthcare Company3$81
Octapharma USA, Inc.4$79
IBSA Pharma Inc.4$78
Scilex Pharmaceuticals Inc.4$68
Jazz Pharmaceuticals Inc.2$67
Bristol Myers Squibb4$66
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$64
Alnylam Pharmaceuticals Inc.2$64
Grifols USA, LLC3$63
Abbott3$61
Biohaven Pharmaceuticals, Inc.4$58
Axsome Therapeutics, Inc.3$57
Avanir Pharmaceuticals, Inc.3$52
Arbor Pharmaceuticals, Inc.4$51
Philips North America LLC2$47
Amneal Pharmaceuticals LLC2$39
Ipsen Biopharmaceuticals, Inc2$38
Revance Therapeutics, Inc.1$33
Neuronetics, Inc.2$31
Tersera Therapeutics LLC1$30
Impel Pharmaceuticals LLC1$28
Vanda Pharmaceuticals Inc.1$27
Almatica Pharma LLC1$25
Assertio Therapeutics, Inc.2$24
Greenwich Biosciences, Inc.1$24

How this compares

$18,214 in reported general payments places this provider in the 75th percentile of 145 neurology providers in Nevada.

See all neurology providers in Nevada →

Medicare billing

Part B allowed, 2024
$51,842
Medicare patients
106
Services billed
1,650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →